CTOs on the Move

Image Stream Medical

www.imagestreammedical.com

 
Image Stream Medical is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Littleton, MA. To find more information about Image Stream Medical, please visit www.imagestreammedical.com
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

georgia ovarian cancer alliance

georgia ovarian cancer alliance is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedRepublic

We`ve created a global health marketplace where patients are empowered to make the healthcare choices that work for them.

Health Dialog

Health Dialog is a total population healthcare services provider that offers risk-bearing entities (health plans, employers, and providers) an integrated suite of services driven by powerful analytics. These services include member engagement programs, multi-channel health coaching, medication adherence support, and shared decision making tools. We are part of the Rite Aid family. Through client partnerships and customized engagements, our dedicated team of healthcare professionals helps clients improve quality of care and reduce healthcare costs while empowering individuals to make informed health and wellness decisions.

Seton Imaging

Seton Imaging is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Buffalo, NY. To find more information about Seton Imaging, please visit www.setonimaging.com

OncoCell MDx

OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, we have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. The first product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of our pipeline. The assay is based on examining specific transcription levels between phagocytic and non-phagocytic cells. This proprietary technology and algorithm has allowed us to not only detect disease but to also, and more importantly, guide the physician as to the grade and aggressiveness of the disease. Our mission is to provide clinicians with quantifiable results that allows professionals to make timely and much more directed medical decisions.